Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNSORB Pk in Children with E. Coli-Associated HUS
NCT00004465Phase 3Terminated
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jul 1997
- Primary completion
- Apr 2001
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 2
01
Overview
A Phase 3 trial of Synsorb Pk in hemolytic uremic syndrome (HUS), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jul 1997; status: terminated.
02
Drugs
Synsorb Pk
03
Conditions
hemolytic uremic syndrome (HUS)
Beyond the preview
Go deeper on NCT00004465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004465.